Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients With Hepatic Neuroendocrine Metastases Using Drug-Eluting Bead Embolization

NCT00730483 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00730483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients With Hepatic Neuroendocrine Metastases Using Drug-Eluting Bead Embolization
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Terminated
Start date
February 28, 2009
Completion date
June 30, 2014
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal carcinoid tumor, islet cell tumor, metastatic cancer